Biobanking & Data Management Platform

The aim of the DZL Biobanking Platform is the SOP-based acquisition, processing, collection, and storage of biomaterial as well as the collection of associated clinical data from the most diverse pulmonary disease areas in compliance with all necessary legal standards. Both scientists within the DZL and external cooperation partners should be able to access biomaterial and data easily and in compliance with the rules. In terms of quality management, the harmonization of ethical and legal documents, data protection concepts, and standard operating procedures associated with quality control and data management is a key objective of all DZL sites.

Scientific Coordinators

Prof. Dr. Andreas Günther (UGMLC)
Dr. Thomas Muley (TLRC)

Administrative  Coordinator

Dr. Jutta Schlegel  (UGMLC)

Central Biobanking Management

Dr. Clemens Ruppert (UGMLC)

Central Data Management

Raphael Majeed (UGMLC)

DZL Ethics Consulting

Gesine Richter (

Background: Biobanking

More information

Contact Central Biobanking Management

Contact page

News about Biobanking & Data Management Platform 

7. July 2021

DZL scientists fills important gap in lung research

Researchers from the DZL's BREATH site in Hanover are the first to clearly demonstrate the existence of lipofibroblasts in the human lung using electron microscopy.
Read More
31. May 2021

First Symposium of the DZL Disease-spanning Research Field Single Cell Analysis

The still relatively young field of single cell analysis has virtually transformed our understanding of the cellular mechanisms of diseases.
Read More
12. May 2021

DZL: broad consent for children

Following the positive vote of the ethics committee at Lübeck University, DZL implements a broad consent for children. ARCN’s biobank BioMaterialBank Nord was in charge of this project.
Read More
All Biobanking platform news